Mechanistically, it has been shown that estrogens upregulate NLRP3 expression via estrogen receptor β (ERβ), which foster cancer cells proliferation; accordingly, NLRP3 knockdown inhibited cancer growth [199]. The gene discussed is NLRP3; the disease is cancer.